BTC $78,394.24 -1.01%
ETH $2,469.94 +0.09%
BNB $698.13 -0.25%
XRP $1.38 -6.38%
SOL $96.77 -1.68%
TRX $0.3357 -1.24%
DOGE $0.0850 -4.04%
ADA $0.2058 -4.20%
BCH $261.33 -2.57%
LINK $11.28 -2.30%
HYPE $80.93 -1.66%
AAVE $123.84 -3.31%
SUI $0.7376 -5.77%
XLM $0.1799 -5.42%
ZEC $780.75 -2.04%
BTC $78,394.24 -1.01%
ETH $2,469.94 +0.09%
BNB $698.13 -0.25%
XRP $1.38 -6.38%
SOL $96.77 -1.68%
TRX $0.3357 -1.24%
DOGE $0.0850 -4.04%
ADA $0.2058 -4.20%
BCH $261.33 -2.57%
LINK $11.28 -2.30%
HYPE $80.93 -1.66%
AAVE $123.84 -3.31%
SUI $0.7376 -5.77%
XLM $0.1799 -5.42%
ZEC $780.75 -2.04%

Sonnet Biotherapeutics 获股东批准与 Hyperliquid Strategies Inc 进行业务合并

2025-12-02 22:26:45

ChainCatcher 消息,据市场消息,纳斯达克上市生物科技公司 Sonnet Biotherapeutics 已获得股东批准,拟与 Hyperliquid Strategies Inc 进行业务合并。

此前消息,Hyperliquid Strategies 提交 S-1 文件,拟募资最高 10 亿美元或用于购入 HYPE 代币。

app_icon
ChainCatcher Building the Web3 world with innovations.